Nutcracker Therapeutics is an early-stage company that is pioneering a revolutionary therapeutic development and manufacturing platform designed to enable the advancement of RNA-based treatments for as many diseases as possible, as fast as possible. As an RNA medicines company, it has combined the power of advanced engineering with high-precision biosynthesis to create a complete RNA platform. The company develops and produces mRNA therapeutics on its proprietary, microfluidic, and biochip-based platform. Nutcracker Therapeutics specializes in a fully-integrated system for the production of mRNA-therapeutics at the push of a button that enables scalable on-demand experimental and manufacturing capacity The company has initiated multiple development programs in collaboration with clinical investigators at leading medical institutions.

‍